• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
MA Lei. Progress in osmotic pump drug delivery system[J]. Journal of China Pharmaceutical University, 2014, 45(6): 726-730. DOI: 10.11665/j.issn.1000-5048.20140620
Citation: MA Lei. Progress in osmotic pump drug delivery system[J]. Journal of China Pharmaceutical University, 2014, 45(6): 726-730. DOI: 10.11665/j.issn.1000-5048.20140620
shu

Progress in osmotic pump drug delivery system

More Information
    Graphical Abstract
    • Abstract
  • Osmotic pump drug delivery system(OPDDS)can obtain an extended drug release at zero-order rate. The release condition is not influenced by the gastric pH and hydrodynamic conditions of the body and exhibits good in vitro-in vivo correlation. Additionally, it can significantly reduce drug administration to one time a day and decrease the fluctuation of drug concentration in plasma, achieving better patient compliance and adherence. Besides, it can improve the therapeutic efficiency of drugs with short biological half-lives, reducing or eliminating the side-effects. Therefore, the OPDDS is a focus of pharmaceutics research. In this article, new progresses in the research of osmotic pump preparations, such as micro-porous osmotic pump drug delivery system, sandwiched osmotic pump drug delivery system, gastric-resident osmotic pump drug delivery system, subcutaneous osmotic pump drug delivery system, are reviewed for the pharmaceutical researchers to design and develop new osmotic pump delivery systems.
    • FullText(HTML)
    • References (28)
  • [1]
    Pradhan R,Kim YI,Chang SW,et al.Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate[J].Int J Pharm,2014, 460(1/2):205-211.
    [2]
    Zhang L,Jiang P,Liu J.Novel sustained-release of propafenone through pellets:preparation and in vitro/in vivo evaluation[J].Int J Mol Sci,2014, 15(9):15 503-15 511.
    [3]
    Khan R,Ashraf MS,Afzal M,et al.Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique[J].J Pharm Bioallied Sci,2014, 6(3):180-184.
    [4]
    Amabile CM,Bowman BJ.Overview of oral modified-release opioid products for the management of chronic pain[J].Ann Pharmacother,2006,40(7/8):1 327-1 335.
    [5]
    Prisant LM,Elliott WJ.Drug delivery systems for treatment of systemic hypertension[J].Clin Pharmacokinet,2003,42(11):931-940.
    [6]
    Michelson EL.Calcium-antagonists in cardiology -update on sustainedrelease drug delivery systems[J].Clin Cardiol,1991, 14(12):947-950.
    [7]
    Malaterre V,Ogorka J,Loggia N,et al.Oral osmotically driven systems:30 years of development and clinical use[J].Eur J Pharm Biopharm,2009, 73(3):311-323.
    [8]
    Wang W,Zhang J,Qi XD.Preparation and drug release mechanism of m-nisoldipine osmotic pump pellets[J].J China Pharm(中国药房),2012,23(33):3 102-3 105.
    [9]
    Liu H,Zhang J,Xu S.Formulation screening and in vitro dissolution model fitting of bupropion hydrochloride microporous osmotic pump tablets[J].China Pharm J(中国药学杂志),2011,46(15):1 179-1 183.
    [10]
    Kumaravelrajan R,Narayanan N,Suba V.Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combination[J].Lipids Health Dis,2011,10(51).doi: 10.1186/1476-511X-10-51.
    [11]
    Kan SL,Li J,Liu JP,et al.Evaluation of pharmacokinetics and pharmacodynamics relationships for salvianolic acid B micro-porous osmotic pump pellets in angina pectoris rabbit[J].Drug Dev Ind Pharm,2014,9(3):137-145.
    [12]
    Wu XL,Wang B.Preparation of microporous ocmotic pump tablets of marine[J].J China Pharm Univ(中国药科大学学报),2010,41(1):45-49.
    [13]
    Liu LX,Ku J,Khang G,et al.Nifedipine controlled delivery by sandwiched osmotic tablet system[J].J Control Release,2000,68(2):145-156.
    [14]
    Qin C,He W,Zhu CL,et al.Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet[J].Int J Pharm,2014,466(1/2):276-285.
    [15]
    Kumaravelrajan R, Narayanan N, Suba V, et al. Simultaneous delivery of nifedipine and metoprolol tartarate using sandwiched osmotic pump tablet system[J].Int J Pharm,2010,399(1/2):60-70.
    [16]
    Guan J,Zhou LY,Nie SF,et al.A novel gastric-resident osmotic pump tablet:in vitro and in vivo evaluation[J].Int J Pharm,2010,383(1/2):30-36.
    [17]
    Fang Y,Pan ZH,Cao DY.Study on preparation and pharmacokinetics of irbesartan floating osmotic pump tablets in dogs[J].J China Pharm(中国药房),2013,24(1):44-46.
    [18]
    Fang Y,Shi QW.Studies on preparation and dissolution test in vitro of intragastric floating two-chamber osmotic pump tablets of total alkaloids of Coptis chinensis and Evodia rutaecarpa[J].J Chin Med Mater(中药材),2011,34(5):779-782.
    [19]
    Hill A,Geißler S,Weigandt M,et al.Control delivery of nanosuspensions from osmotic pumps:Zero order and non-zero order kinetics[J].J Control Release,2012,158(3):403-412.
    [20]
    Brigham E,Wong A,Rampurna G,et al.Variable effects of the gamma-secretase inhibitor ELND006 on Aβ across different compartments(brain,ISF,CSF,and plasma)following sustained exposure via subcutaneous osmotic pumps in wild-type mice[J].Alzheimers Dement,2011,7(4):S313-S314.
    [21]
    Zhang X,Yi YN,Qi JP,et al.Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets:near zero-order release and pharmacokinetics in dogs[J].Int J Pharm,2013, 452(1/2):233-240.
    [22]
    Wei L,Li J,Guo L,et al.Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol[J].Drug Dev Ind Pharm,2007,33(9):990-998.
    [23]
    Ouyang D,Nie S,Li W,et al.Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets[J].J Pharm Pharmacol,2005, 57(7):817-820.
    [24]
    Chaudhary A,Tiwari N,Jain V,et al.Microporous bilayer osmotic tablet for colon-specific delivery[J].Eur J Pharm Biopharm,2011,78(1):134-140.
    [25]
    Xin TG,Zhao Y,Jing HP,et al.A time-released osmotic pump fabricated by compression-coated method:formulation screen,mechanism research and pharmacokinetic study[J].Asian J Pharm Sci,2014,9(4):208-217.
    [26]
    Yang CH,Liu H,Lu L,et al.Preparation and formulation design of trimetazidine dihydrochloride time-controlled osmotic pump tablets[J].Chin J Hosp Pharm(中国医院药学杂志),2014,34(8):599-604.
    [27]
    Duan HY,Zhang S,Zhu PF,et al.Preparation of osmotic pump controlled release tablets of Panax Notoginoside[J].Chin J Exp Tradit Med Form(中国实验方剂学杂志),2010, 16(6):6-10.
    [28]
    Chen FW,Guo Z,Li HY,et al.Correlation of Fuzilizhong chemome release from osmotic pump tablets and instrinsic dissolution characteristics from powders[J].J China Pharm Univ(中国药科大学学报),2012,43(4):329-333.
    • Related Articles

  • Related Articles

    [1]SHI Qinqing, WANG Jinghua, CHENG Manman, YIN Lifang, QIN Chao. Preparation and in vitro release of ivabradine hydrochloride elementary osmotic pump tablets[J]. Journal of China Pharmaceutical University, 2021, 52(3): 311-317. DOI: 10.11665/j.issn.1000-5048.20210307
    [2]ZHU Ling, QIN Chao, WU Jinlian, CHEN Yuhong, YIN Lifang. Preparation and in vitro evaluation of pregabalin controlled porosity osmotic pump tablets[J]. Journal of China Pharmaceutical University, 2019, 50(1): 53-58. DOI: 10.11665/j.issn.1000-5048.20190107
    [3]WANG Shu, ZHANG Zhenhai, GU Dongfei, ZHOU Jianping, LYV Huixia. Advances of exosomes as a new drug delivery system[J]. Journal of China Pharmaceutical University, 2014, 45(2): 247-252. DOI: 10.11665/j.issn.1000-5048.20140221
    [4]WU Qu, HUO Meirong, ZHOU Jianping. Advances on novel drug delivery system[J]. Journal of China Pharmaceutical University, 2013, 44(2): 97-104. DOI: 10.11665/j.issn.1000-5048.20130201
    [5]CHI Xue-mei, CUI Si-si, CAO Jie, TIAN Jun-mei, GU Yue-qing. A novel thermo-sensitive nano drug-delivery system triggered by near-infrared light[J]. Journal of China Pharmaceutical University, 2012, 43(2): 147-153.
    [6]KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15.
    [7]Preparation of microporous osmotic pump tablets of marine[J]. Journal of China Pharmaceutical University, 2010, 41(1): 45-49.
    [8]Novel evaluation theories of kinetics for controlled-release drug delivery systems[J]. Journal of China Pharmaceutical University, 2008, 39(1): 60-63.
    [9]Studies on Optimizing the Formula of Nitrendipine Selfemulsifying Drug Delivery System[J]. Journal of China Pharmaceutical University, 2004, (3): 17-20.
    [10]Development of Verapamil Hydrochloride Self-Emulsifying Sustained-Release Tablets and Exploration of Released Character[J]. Journal of China Pharmaceutical University, 2002, (3): 42-44.

Catalog

    Get Citation
    PDF
    XML
    Article views (1853) PDF downloads (1281) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：278745

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return